Trials / Completed
CompletedNCT04507763
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Ankylosing Spondylitis (AS) With Etanercept
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 763 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate available data in Iraqi patients with ankylosing spondylitis on Enbrel treatment with regards to the impact of early treatment using data from the Baghdad Teaching Hospital registry
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept | Patients with ankylosing spondylitis as provided in real world practice |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2020-08-11
- Last updated
- 2021-10-28
- Results posted
- 2021-10-28
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT04507763. Inclusion in this directory is not an endorsement.